期刊文献+

充血性心力衰竭患者血清CA125和NT-proBNP水平测定及其临床意义

Clinical Significance of Determination of Serum CA125 and NT-proBNP Levels in Patients with Congestive Heart Failure
暂未订购
导出
摘要 【目的】探讨慢性充血性心力衰竭(CHF)患者血清糖类抗原125(CAl25)及N末端B型钠尿肽原(NTproBNP)水平与患者心功能及其相关因素之间的关系。【方法】180例CHF患者通过超声测定左室内径及左室射血分数(LVEF),以电化学发光法(ECLIA)测定其血清CAl25和NT—proBNP水平,所有患者根据纽约心功能分级标准分为Ⅱ、Ⅲ、Ⅳ级组。另随机抽取40例有心血管疾病但无CHF的患者作为非CHF组。【结果】①CHF组血清CAl25及NTproBNP水平高于非CHF组,Ⅳ级心功能组水平明显高于Ⅲ级组,且Ⅲ级组明显高于Ⅱ级组;②血清CAl25及NT-proBNP水平均与LVEF呈负相关,而与导致CHF的原发病种类不相关。[结论]CHF患者血清CAl25及NT-proBNP水平升高,并且其水平与LVEF有关,而与导致CHF的原发病种类无关。 [Objective]To study the relation among the levels of serum carbohydrate antigen-125 (CA125) and plasma N terminal pro-natrinretic peptide(NT-proBNP) as well as the heart function in patients with con- gestive heart failure(CHF) . [Methods] One hundred and eighty patients with CHF were divided into three groups based on the standard of New York Heart Association Classification. Forty patients with cardiovascular disease but without CHF were served as control. The level of CA125 and BNP was measured by electrochem- iluminescence(ECIflA). Left ventrlcular diameter and left ventricular ejection fraction (LVEF) was detected by echocardiography. [Results]Levels of CA125 and NT-proBNP in the patients with CHF were much higher than those without CHF, and were negatively associated with the LVEF independent of different kind of heart diseases. [Conclusion]Levels of CA125 and NT proBNP in patients with CHF are higher than those without CHF and they are related to the LVEF independent of the kinds of heart diseases.
出处 《医学临床研究》 CAS 2011年第1期35-36,39,共3页 Journal of Clinical Research
关键词 心力衰竭 充血性/血液 抗原 肿瘤相关 碳水化合物/血液 heart failure,congestive/BL antigens,tumor-associated,carbohydrate/BL
  • 相关文献

参考文献6

  • 1D'aloiaa,Fagianop,Aurigemmag.Serum levels of carbohydrate antigen 125 in patient swith chronic heart failure:relation to clinical severity,hemodynamic and Doppler echocardiographic abnormalities,and short-term prognosis[J].J Am Coll Cardiol,2003,41(10):1805-1811.
  • 2Kouris NT,Zacharos ID,Kontogianni DD,et al.The significance of CA125 levels in patients with chronic congestive heart failure.Correlation with clinical and echocardiographic parameters[J].Eur J Heart Fail,2005,7(2):199-203.
  • 3Nunez J,Sanchis J,BodiV,et al.Improvement in risk stratification with the combination of the tumour marker antigen carbohydrate 125 and brain natriuretic peptide in patients with acute heart failure[J].Eur Heart J.2010,31(14):1752-1763.
  • 4李锡明,马冬辉.充血性心力衰竭患者B型尿钠肽与肝功能异常的临床意义[J].医学临床研究,2004,21(9):989-991. 被引量:6
  • 5Vizzardi E,Nodari S,D'Aloia A,et al.CA 125 tumoral marker plasma levels relate to systolic and diastolic ventricular function and to the clinical status of patients with chronic heart failure[J].Echocardiography,2008,25(9):955-960.
  • 6Dmanc,Ercane,Tengizi,et al.Elevated serum CA 125 levels in mitral stenotic patients with heart failure[J].Cardiology,2003,100(2):7-10.

二级参考文献10

  • 1Cheung BMY, Kumana CR. Natriuretic peptide: relevance in cardiac disease[J].JAMA,1998,280(23):1983-1984.
  • 2Yoshimura M, Yasue H, Okamura K,et al. Different secretion pattern of atrial natriuretic peptide and brain natruretic peptide in patients with CHF[J].Circulation,1993,87(2):464-469.
  • 3McDonagh TA, Robb SD, Murdoch DR, et al. Biochemical detection of left-ventricular systolic dysfunction[J].Lancet,1998,351(9095):9-13.
  • 4Kawai K, Hata K, Tokaoka H, et al. Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated cardiomyopathy during β-blocker therapy : A potential of hormone-guided treatment[J].Am Heart J,2001,141(6):925-932.
  • 5Troughton RW, Frampton CM, Yandle TG, et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations[J].Lancet,2000,355(9210):1126-1132.
  • 6Maisel AS, Krishnaswamy P, Nowak RM, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure[J].N Engl J Med,2002,347(3):161-167.
  • 7Bynum TE, Boinott JK, Meddrey WC. Ischemic hepatitis[J].Diag Dis Sci,1979,24(2):129-135.
  • 8Leithe ME, Margorien RD, Hemiller JB, et al. Relationship between central hemodynamics and regional blood flow in normal subjects and in patients with congestive heart failure[J].Circulation,1984,69(1):57-64.
  • 9Wanless IR, Lin JJ, Butang J. Role of thrombosis in the pathogenesis of CLF(cardiac cirrhosis)[J].Hepatology,1995,21(5):1232-1237.
  • 10Kubo C, Walter BA, John DHA, et al. Liver function abnormalities in chronic heart failure. Influence of systemic hemodynamics[J].Arch Intern Med,1987,147(7):1227-1230.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部